Ozari vs Remedy Meds: Two Flat Prices, $213 Apart

Published July 16, 2026

When the Model Is the Same, Only the Number Matters

Most GLP-1 comparisons involve untangling different pricing structures — memberships here, dose tiers there, intro rates somewhere else. This one is refreshingly simple.

Remedy Meds built its reputation on flat-rate clarity: roughly $299/month, all-in, for compounded GLP-1s. Fast access, no games, price you can predict. That's the right model — it's the same one Ozari uses.

Which makes this the rare comparison that reduces to arithmetic. Flat $299 versus flat $86 for semaglutide is $2,556/year of difference for the same pricing philosophy, the same medication category (compounded, not FDA-approved, licensed US pharmacies), and the same no-commitment structure.

The Whole Comparison in One Table

	Ozari Health	Remedy Meds
Pricing model	Flat, all-in	Flat, all-in
Compounded semaglutide	From $86/month	~$299/month
Compounded tirzepatide	From $125/month	~$299+/month
Membership fee	None	None
Dose-tier increases	No	No
12-month semaglutide	~$1,562–$2,100	~$3,588
Spanish platform	Yes — /es	No
Certification	LegitScript certified	Established provider

The Fair Question: Why Is Ozari Cheaper?

A $213/month gap on the same model deserves an explanation, because "too cheap" is itself a red flag in this market. Ozari's price reflects a deliberately lean structure: no paid-coaching layer, no branded-advertising overhead passed to patients, direct 503A pharmacy relationships, and published-price discipline across one clear product line. What it doesn't reflect is skipped steps — licensed provider review before every prescription, LegitScript certification, named pharmacy partners, and clinical support are all in the $86. Our transparency review documents each claim with verification links.

Frequently Asked Questions

Are Remedy Meds and Ozari's medications the same type?

Both prescribe compounded semaglutide and tirzepatide through licensed US compounding pharmacies under patient-specific prescriptions. Neither is FDA-approved — true of all compounded GLP-1s.

Why is Ozari $213 cheaper for the same model?

Leaner cost structure, not fewer safeguards: no coaching overhead, direct pharmacy relationships, and flat published pricing — with licensed review and LegitScript certification retained.

Does either require a commitment?

No. Both are month-to-month friendly; Ozari's best rate ($86) comes on a 3-month starter plan for eligible first-time patients, not an annual contract.

How fast can I start with each?

Both are among the faster options — days from intake to shipment after provider approval. Start Ozari's intake here.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Compounded medications are not FDA-approved and are not generic versions of branded products. Competitor pricing was verified at the time of writing and may change — confirm current pricing directly with each provider. Individual results vary. Always consult a licensed healthcare provider before starting any prescription medication.

Sources

cost